BioPreviously, Dr. Herlihy served as CEO and President of Repligen from 1996 to 2015. Under his leadership, Repligen grew from a market capitalization of approximately $20 million to in excess of $1 billion and became one of the leading bioprocessing companies in the United States. Repligen was one of the earliest investments made by BMVF.
Education
Degrees
Start Free Trial
Access "Walter Herlihy" Work Experience (Current/Past), Board Seats, Joined Date, Contact Details - Emailid/Phone and Investments (If any) in one connected platform (AcquityData).